Rotavirus is the leading cause of severe gastroenteritis in young children worldwide. A vaccine to prevent a rotavirus infection would prevent over 500,000 deaths/year in developing countries and save the United States over $1 billion a year in health care costs, but recently, the only licensed vaccine was withdrawn due to associated side effects. Protection from rotavirus infection and resulting disease is dependent on the initiation and maintenance of an immunological response. The goal of this application is to understand and compare the difference in protective immunological responses induced by a live rotavirus infection and by a non-replicating subunit vaccine (VLPs). The immunological response to both live rotavirus infection and a VLP vaccine will be differentiated by many factors including the time of response, the type of cells that control the response, and establishment of immunological memory. In mice, rotavirus infection and VLP vaccination can induce sterilizing immunity. The exact mechanisms through which rotavirus and VLPs induce sterilizing immunity in the mouse have not been elicited. I hypothesize that (i) clearance of and sterilizing immunity established by a primary rotavirus infection occurs predominately as a result of T cell independent B lymphocyte activation, and (ii) VLP vaccination will cause sterilizing immunity through T cell dependent B lymphocyte activation. To test this hypothesis, flow cytometry will be used to identify, quantitate, and functionally characterize activated lymphocyte subsets during clearance of a primary rotavirus infection, after vaccination with VLPs, and after a rotavirus challenge of previously infected or VLP vaccinated mice. These will be the first studies to systematically identify and compare subsets of activated lymphocytes between a live infected and VLP vaccinated animal and correlating these responses with protection from infection. Understanding the mechanisms of how rotavirus and vaccination with VLPs activate the immune system to induce sterilizing immunity will aid in better vaccine design and may identify benchmarks for testing potential vaccine effectiveness in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI010604-01A1
Application #
6340149
Study Section
Special Emphasis Panel (ZRG1-IMB (20))
Program Officer
Podskalny, Judith M
Project Start
2001-02-25
Project End
Budget Start
2001-02-25
Budget End
2002-02-24
Support Year
1
Fiscal Year
2001
Total Cost
$40,196
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Blutt, Sarah E; Warfield, Kelly L; Estes, Mary K et al. (2008) Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. J Virol 82:3135-8
Blutt, Sarah E; Matson, David O; Crawford, Sue E et al. (2007) Rotavirus antigenemia in children is associated with viremia. PLoS Med 4:e121
Warfield, Kelly L; Blutt, Sarah E; Crawford, Sue E et al. (2006) Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol 80:12377-86
Blutt, Sarah E; Warfield, Kelly L; O'Neal, Christine M et al. (2006) Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine 24:1170-9
Blutt, Sarah E; Kirkwood, Carl D; Parreno, Viviana et al. (2003) Rotavirus antigenaemia and viraemia: a common event? Lancet 362:1445-9
Ciarlet, Max; Crawford, Sue E; Cheng, Elly et al. (2002) VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol 76:1109-23
Blutt, Sarah E; Warfield, Kelly L; Lewis, Dorothy E et al. (2002) Early response to rotavirus infection involves massive B cell activation. J Immunol 168:5716-21